Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
Status:
Recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the proposed study is to establish the safety of combining irinotecan
chemotherapy with 5-FU, leucovorin/folinic acid, oxaliplatin, and docetaxel (abbreviated as
the I-FLOAT study of gFOLFOXIRITAX) chemotherapies (leucovorin/folinic acid is a vitamin to
make 5-FU work well).